FibroBiologics has released its annual report Form C-AR for the year ended December 31, 2022 – FibroBiologics is a clinical-stage cell therapy company focused on developing and commercializing fibroblast cell-based and fibroblast cell-derived product candidates as therapeutics for patients suffering from chronic diseases with significant unmet medical needs.
FibroBiologics has released its annual report Form C-AR
- May 1, 2023